Abstract
Novel drug delivery systems (NDDS) delivered the active molecules to the target site in a defined manner for produce the desired effects without disturbing the delicate bio-environment. Among many available colloidal drug delivery systems, Liposomes (a class based on phospholipids) have attracted more attention than other systems due to many meritorious features such as excellent chemical & biological stability, good solubilisation power, promote intracellular delivery of bio-active molecules, reduce the uptake of macrophages and encapsulate both hydrophilic as well as lipophillic drug molecule. In this review article, I try to give some basic knowledge about these carrier systems in tabular form, which is more understandable concept as compared to simple text form.
Keywords: Cell delivery, drug targeting, gene delivery, liposome, phospholipids.
Drug Delivery Letters
Title:Liposomes: Targeted and Controlled Delivery System
Volume: 4 Issue: 1
Author(s): Tarun Garg and Amit K. Goyal
Affiliation:
Keywords: Cell delivery, drug targeting, gene delivery, liposome, phospholipids.
Abstract: Novel drug delivery systems (NDDS) delivered the active molecules to the target site in a defined manner for produce the desired effects without disturbing the delicate bio-environment. Among many available colloidal drug delivery systems, Liposomes (a class based on phospholipids) have attracted more attention than other systems due to many meritorious features such as excellent chemical & biological stability, good solubilisation power, promote intracellular delivery of bio-active molecules, reduce the uptake of macrophages and encapsulate both hydrophilic as well as lipophillic drug molecule. In this review article, I try to give some basic knowledge about these carrier systems in tabular form, which is more understandable concept as compared to simple text form.
Export Options
About this article
Cite this article as:
Garg Tarun and K. Goyal Amit, Liposomes: Targeted and Controlled Delivery System, Drug Delivery Letters 2014; 4 (1) . https://dx.doi.org/10.2174/22103031113036660015
DOI https://dx.doi.org/10.2174/22103031113036660015 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets Minocycline Repurposing in Critical Illness: Focus on Stroke
Current Topics in Medicinal Chemistry Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug
Current Diabetes Reviews Impact of HbA1C (Glycated Hemoglobin) and Glucose on Outcomes of Mechanical Thrombectomy in Patients with Large Artery Occlusion
Current Neurovascular Research Augmentation Therapy with Alpha1-antitrypsin: Novel Perspectives
Cardiovascular & Hematological Disorders-Drug Targets MicroRNAs and the Heart: Small Things Do Matter
Current Topics in Medicinal Chemistry Parkinson's Disease, Diabetes and Cognitive Impairment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Complement and Microglia in the Neuropathogenesis of HIV Infection: Pro- and Anti-Inflammatory Aspects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Heat Shock Protein (HSP) in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Medicinal Chemistry Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets FKBP Ligands as Novel Therapeutics for Neurological Disorders
Mini-Reviews in Medicinal Chemistry Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?
Current Drug Targets Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Current Medicinal Chemistry Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry Modulation of Neutrophil Development and Homeostasis
Current Molecular Medicine Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review
Current Diabetes Reviews Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke
Current Medicinal Chemistry Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases
Current Pharmaceutical Design The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders
Current Molecular Medicine